Menin Inhibitors 101 with Dr. Joshua Zeidner

Menin Inhibitors 101 with Dr. Joshua Zeidner
Event Description
What are menin inhibitors? How are they used in AML care? Listen to this pre-recorded podcast episode to hear Dr. Joshua Zeidner, an AML expert and lead researcher in menin inhibitors, answer these questions and more by sharing data from one of his recent studies.
Schedule & Agenda

Mary Arnett interviews Dr. Joshua Zeidner on all things menin inhibitors and Dr. Zeidner's recent study.

Mary Arnett interviews Dr. Joshua Zeidner on all things menin inhibitors and Dr. Zeidner's recent study.
Speakers & Moderators

Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Dr. Zeidner specializes in the management of patients with acute leukemia, MDS, and MPNs. His research focuses on developing innovative methods to improve clinical outcomes in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Dr. Zeidner is the Chief of the Leukemia Research Program at the University of North Carolina.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org

Get the latest thought leadership on your Chronic Lymphocytic Leukemia delivered straight
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.